| Mrs Shatarra Tavonia Salley, APRN, FNP-C, PMHNP | |
|
2400 Boiling Springs Rd, Boiling Springs, SC 29316-5304 | |
| (864) 599-0731 | |
| (864) 599-0791 |
| Full Name | Mrs Shatarra Tavonia Salley |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 2400 Boiling Springs Rd, Boiling Springs, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639795859 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 24906 (South Carolina) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 24906 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Greenville Memorial Hospital | Greenville, SC | Hospital |
| Spartanburg Medical Center | Spartanburg, SC | Hospital |
| Prisma Health Patewood Hospital | Greenville, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
The Breast Health Global Initiative and the Latin American & Caribbean Society of Medical Oncology will convene the fourth biennial BHGI Global Summit on International Breast Health June 9-11, 2010 in Chicago, bringing together collaborating national and international organizations to address the optimization of breast health care delivery in limited-resource countries.
Novartis today announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) compared to Tafinlar monotherapy alone.
Scientists at the National Institutes of Health and other institutions have devised a new strategy to stop tumors from developing the new blood vessels they need to grow.
Mayo Clinic has announced a new network relationship with UnitedHealthcare, giving UnitedHealthcare commercial plan customers in-network access to Mayo Clinic physicians and hospitals beginning Nov. 1, 2010.
Emodin, a natural product that can be extracted from various Chinese herbs including Rheum palmatum and Polygonum cuspidatum, shows promise as an agent that could reduce the impact of type 2 diabetes. Findings published in this month's edition of the British Journal of Pharmacology show that giving emodin to mice with diet-induced obesity lowered blood glucose and serum insulin, improved insulin resistance and lead to more healthy levels of lipid in the blood. It also decreased body weight and reduced central fat mass.
› Verified 7 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
The Breast Health Global Initiative and the Latin American & Caribbean Society of Medical Oncology will convene the fourth biennial BHGI Global Summit on International Breast Health June 9-11, 2010 in Chicago, bringing together collaborating national and international organizations to address the optimization of breast health care delivery in limited-resource countries.
Novartis today announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) compared to Tafinlar monotherapy alone.
Scientists at the National Institutes of Health and other institutions have devised a new strategy to stop tumors from developing the new blood vessels they need to grow.
Mayo Clinic has announced a new network relationship with UnitedHealthcare, giving UnitedHealthcare commercial plan customers in-network access to Mayo Clinic physicians and hospitals beginning Nov. 1, 2010.
Emodin, a natural product that can be extracted from various Chinese herbs including Rheum palmatum and Polygonum cuspidatum, shows promise as an agent that could reduce the impact of type 2 diabetes. Findings published in this month's edition of the British Journal of Pharmacology show that giving emodin to mice with diet-induced obesity lowered blood glucose and serum insulin, improved insulin resistance and lead to more healthy levels of lipid in the blood. It also decreased body weight and reduced central fat mass.
› Verified 7 days ago
| Entity Name | Itrust Wellness Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629517222 PECOS PAC ID: 0648532028 Enrollment ID: O20180322002663 |
News Archive
The Breast Health Global Initiative and the Latin American & Caribbean Society of Medical Oncology will convene the fourth biennial BHGI Global Summit on International Breast Health June 9-11, 2010 in Chicago, bringing together collaborating national and international organizations to address the optimization of breast health care delivery in limited-resource countries.
Novartis today announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) compared to Tafinlar monotherapy alone.
Scientists at the National Institutes of Health and other institutions have devised a new strategy to stop tumors from developing the new blood vessels they need to grow.
Mayo Clinic has announced a new network relationship with UnitedHealthcare, giving UnitedHealthcare commercial plan customers in-network access to Mayo Clinic physicians and hospitals beginning Nov. 1, 2010.
Emodin, a natural product that can be extracted from various Chinese herbs including Rheum palmatum and Polygonum cuspidatum, shows promise as an agent that could reduce the impact of type 2 diabetes. Findings published in this month's edition of the British Journal of Pharmacology show that giving emodin to mice with diet-induced obesity lowered blood glucose and serum insulin, improved insulin resistance and lead to more healthy levels of lipid in the blood. It also decreased body weight and reduced central fat mass.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Shatarra Tavonia Salley, APRN, FNP-C, PMHNP 121 Commons Way, Greenville, SC 29611-3850 Ph: (864) 520-2020 | Mrs Shatarra Tavonia Salley, APRN, FNP-C, PMHNP 2400 Boiling Springs Rd, Boiling Springs, SC 29316-5304 Ph: (864) 599-0731 |
News Archive
The Breast Health Global Initiative and the Latin American & Caribbean Society of Medical Oncology will convene the fourth biennial BHGI Global Summit on International Breast Health June 9-11, 2010 in Chicago, bringing together collaborating national and international organizations to address the optimization of breast health care delivery in limited-resource countries.
Novartis today announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) compared to Tafinlar monotherapy alone.
Scientists at the National Institutes of Health and other institutions have devised a new strategy to stop tumors from developing the new blood vessels they need to grow.
Mayo Clinic has announced a new network relationship with UnitedHealthcare, giving UnitedHealthcare commercial plan customers in-network access to Mayo Clinic physicians and hospitals beginning Nov. 1, 2010.
Emodin, a natural product that can be extracted from various Chinese herbs including Rheum palmatum and Polygonum cuspidatum, shows promise as an agent that could reduce the impact of type 2 diabetes. Findings published in this month's edition of the British Journal of Pharmacology show that giving emodin to mice with diet-induced obesity lowered blood glucose and serum insulin, improved insulin resistance and lead to more healthy levels of lipid in the blood. It also decreased body weight and reduced central fat mass.
› Verified 7 days ago
Blair Gault, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1888 Boiling Springs Rd, Boiling Springs, SC 29316 Phone: 866-389-2727 | |
Mrs. Constance Audrianna Mudda, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2400 Boiling Springs Rd, Boiling Springs, SC 29316 Phone: 864-599-0731 Fax: 864-599-0791 | |
Rebecca Joy Brown, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 316 Village Creek Dr, Boiling Springs, SC 29316 Phone: 864-327-9003 Fax: 800-253-0649 | |
Charlotte Anne Davis, APRN, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 316 Village Creek Dr, Boiling Springs, SC 29316 Phone: 864-327-9003 | |
Virginia Lee Ivey-mingione, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 110 Parris Bridge Road, Boiling Springs, SC 29316 Phone: 864-599-1998 | |
Jennifer Nicole Gahan, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1888 Boiling Springs Rd, Boiling Springs, SC 29316 Phone: 864-599-0920 | |
Felisha Booker, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1214 Turning Leaf Cir, Boiling Springs, SC 29316 Phone: 864-814-8660 |